NBTY Targets Unleashing Growth From Private Label Drag
This article was originally published in The Tan Sheet
Executive Summary
“Where we have opportunities to hold on to” private label business, “we'll hold on to it, but not at any cost,” says President and CEO Steve Cahillane. “Due to private label margins” becomes common refrain in NBTY’s income downturn.
You may also be interested in...
NBTY Cuts Its Losses, Leaving Contract Manufacturing
The supplement manufacturer and retailer says it will cease contract manufacturing as it increases its focus on growing its branded product and retail businesses, particularly internationally. Private label production continues but will become a smaller part of its business.
NBTY Cuts Its Losses, Leaving Contract Manufacturing
The supplement manufacturer and retailer says it will cease contract manufacturing as it increases its focus on growing its branded product and retail businesses, particularly internationally. Private label production continues but will become a smaller part of its business.
Private Label: A Riddle Wrapped In A Mystery Inside An Enigma For Major Supplement Manufacturers
GNC looks at restoring growth to its private label and contract manufacturing business and Vitamin Shoppe works on getting its business growing, but NBTY continues to lament the drag the segment is having on its overall growth.